financetom
Business
financetom
/
Business
/
US fertilizer imports helping fund Russian war effort, CF Industries says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US fertilizer imports helping fund Russian war effort, CF Industries says
May 2, 2024 1:02 PM

May 2 (Reuters) - U.S. agriculture companies have been

brisk importers of Russian fertilizer since the 2022 Ukraine

invasion, a practice that is unwittingly helping fund Russia's

war against Ukraine, U.S. producer CF Industries ( CF ) said on

Thursday.

The U.S. does not impose sanctions directly on Russian

fertilizer, which is important to global food supplies and

prices. On Wednesday, the U.S. Treasury Department issued

hundreds of fresh sanctions on other Russian targets over the

war.

"What's kind of shocking is there's been all of this focus

on not funding the Russian war machine and not buying Russian

gas," CF's CEO Tony Will said on a quarterly earnings call. "And

yet, the U.S. is arms wide open to take urea and UAN (urea

ammonium nitrate) coming out of Russia, which is effectively

just natural gas that's been converted (into fertilizer).

"So the U.S. is funding the very war effort over there that

on the one hand it's condemning."

A White House spokesperson did not immediately respond to a

request for comment.

CF, based in Illinois, is one of the world's biggest

nitrogen fertilizer producers and competes against Russian

imports. Nitrogen fertilizer is made from natural gas and the

U.S. has imposed sanctions on a project owned by Russia's

largest producer of liquefied natural gas.

CF does not import Russian fertilizer, company spokesperson

Chris Close said.

Will did not say whether CF is calling on the U.S. to

sanction Russian fertilizer.

Wholesale producers typically sell fertilizer to separate

retail companies that sell it directly to farmers, or through

their own retail stores.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
MilliporeSigma to Acquire Chromatography Business of JSR Life Sciences, Expanding Protein A Capabilities and Downstream Portfolio
Oct 15, 2025
Acquisition aims to strengthen company’s downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphere™ Protein A resin technology complements the company’s existing biologics portfolio Enhances the company’s capabilities to accelerate next-generation therapies by optimizing antibody purification BURLINGTON, Mass.--(BUSINESS WIRE)-- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology...
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
Oct 15, 2025
EB-003, Enveric’s lead product candidate, is protected by a different patent family that includes an issued U.S. patent and pending U.S. and international patents, all of which are separate and distinct from the patent that appears relevant to Bretisilocin CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Enveric Biosciences ( ENVB ) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to...
Emmis Acquisition Corp.  Announces Upcoming Automatic Unit Separation
Emmis Acquisition Corp. Announces Upcoming Automatic Unit Separation
Oct 15, 2025
New York, NY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Emmis Acquisition Corp. ( EMISU )  (the “Company”) announced today that, effective as of October 22, 2025, the Company’s units will no longer trade, and that the Company’s Class A ordinary shares and rights, which together comprise the units, will commence trading separately. The Class A ordinary shares and rights will...
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond
Oct 15, 2025
Second Acquisition in Three Months Builds Momentum NEW YORK--(BUSINESS WIRE)-- Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare industry, continues to strengthen its media capabilities by acquiring Spring & Bond. A digital media agency known for its omnichannel-first approach and data-driven solutions, Spring & Bond is focused exclusively on healthcare, working with leading healthcare...
Copyright 2023-2026 - www.financetom.com All Rights Reserved